[3P-0359] Flotillin-1 correlates with H-Ras-regulated breast cancer aggressiveness

Minsoo Koh¹、Hae-Young Yong¹、Eun-Sook Kim¹、Hwajin Son¹、You Rim Jeon¹、Jin-Sun Hwang¹、Myeong-Ok Kim¹、Yujin Cha¹、Wahn Soo Choi²、Dong-Young Noh³、Jae-Seon Lee⁴、Hong-Hee Kim⁵、So Yeon Park⁶、Woo Kyung Moon⁷、Hyeong-Reh Choi Kim⁸、〇Aree Moon¹ (1.Coll. of Pharm., Duksung Womens Univ., Korea、2.Dept. of Immun., Sch. of Med., Konkuk Univ., Korea、3.Dept. of Sur. and Cancer Research Inst., Coll. of Med., Seoul National Univ., Korea、4.Dept. of Mole. Med., Coll. of Med., Inha Univ., Korea、5.Dept. of Cell and Developmental Biol., Seoul Nat. Univ., Korea、6.Dept. of Path., Seoul Nat.Univ. College of Medicine, Seoul Nat. Uni. Bundang Hospital, Korea、7.Dept. of Rad., Seoul Nat. Univ. Hospital, Korea、8.Dept. of Path., Wayne State Univ. Sch. of Med., USA)

Flotillin-1, H-Ras, Invasion, Triple-Negative Breast Cancer